🔎 Trials Near Me

Akèy › Maladi poumon entèstisyèl › North Carolina

Etid klinik pou Maladi poumon entèstisyèl nan North Carolina

18 etid pou Maladi poumon entèstisyèl ap chèche patisipan nan sit nan North Carolina.

Vil nan North Carolina

Tèks ofisyèl etid la (Anglè)

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

  • Coastal Carolina Health Care, P.A. Pulmonary and Sleep Medicine, New Bern
  • Southeastern Research Center-Winston-Salem-61365, Winston-Salem
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07540988

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • CTR South Cary, Cary
  • Onsite Clinical (Rowan Diagnostic), Salisbury
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 29, 2026 · NCT05798923

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

  • GSK Investigational Site, Durham
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06572384

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

  • University of North Carolina at Chapel Hill, Chapel Hill
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06968845

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

  • Southeastern Research Center, Winston-Salem
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06911632

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

  • Clinical Research Site, Greensboro
Ap rekriteFaz 2
Laj 18 a 85 · Tout sèks · Mizajou Sep 2, 2026 · NCT07333183

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • University of North Carolina at Chapel Hill, Chapel Hill
  • Duke University School of Medicine, Durham
  • Pulmonix, LLC, Greensboro
  • ak 2 plis
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT06388421

Platform Clinical Study for Conquering Scleroderma

  • Duke University Medical Center, Durham
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT06195072

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

  • Duke University, Durham
Ap rekriteFaz 2/3
Laj 18 a 75 · Tout sèks · Mizajou Aug 17, 2026 · NCT06328777

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

  • UNC Chapel Hill, Chapel Hill
  • Duke University, Durham
  • Pulmonix LLC, Greensboro
  • ak 1 plis
Ap rekriteEtid obsèvasyon
Laj 21 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT01915511

H01 in Adults With Interstitial Lung Disease (The SOLIS Study)

  • NIEHS Clinical Research Unit (CRU), Research Triangle Park
Ap rekriteFaz 2
Laj 18 a 100 · Tout sèks · Mizajou Jul 28, 2026 · NCT06325696

Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease

  • Duke University Health System, Durham
Ap rekriteFaz 2
Laj 4 ak plis · Tout sèks · Mizajou Jul 22, 2026 · NCT04925375

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  • Duke University Medical Center, Durham
  • PulmonIx LLC, Greensboro
  • East Carolina University, Greenville
  • ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jul 13, 2026 · NCT05943535

Pulmonary Hypertension SOLAR

  • Duke University Medical Center, Durham
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Feb 24, 2026 · NCT04778046

129Xe MRI Cardiopulmonary

  • Duke University Medical Center, Durham
Ap rekriteFaz 2Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Feb 4, 2026 · NCT06038630

Hyperpolarized 129Xe MRI for Imaging Pulmonary Function

  • Duke University Medical Center, Durham
Ap rekriteFaz 2Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jan 16, 2026 · NCT01280994

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

  • Southeastern Research Center, Winston-Salem
Ap rekriteFaz 2
Laj 40 ak plis · Tout sèks · Mizajou Nov 12, 2025 · NCT05975983

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.